ECHA’s Registry of CLH intentions until outcome for talc (Mg3H2(SiO3)4; CAS 14807-96-6; EC 238-877-9) shows an administrative update dated 2026-02-04 and confirms the CLH process status as “Opinion Adopted.” The entry indicates RAC adopted its opinion on 2024-09-20 and that the RAC opinion was published on 2025-07-09. The RAC opinion supports harmonised classification of talc as Carc. 1B (H350) and STOT RE 1 (H372; lungs; inhalation). This is not yet a legally binding change to CLP Annex VI (no ATP adoption indicated here), but it is a key milestone that compliance teams should track because it can precede an EU Commission ATP that would trigger mandatory classification/labeling and SDS updates for talc and mixtures containing it.
ECHA’s official CLH registry entry for talc (EC 238-877-9; CAS 14807-96-6) shows a registry metadata update dated 04-Feb-2026. The entry continues to reflect that RAC’s opinion has been adopted (with the opinion published in July 2025 per the registry remarks). While this is not a legally binding CLP Annex VI change, it is a trackable process milestone for compliance teams monitoring when talc’s harmonised classification may progress to European Commission adoption and subsequent downstream obligations (e.g., SDS/label updates once an ATP is enacted).
The UK Health and Safety Executive published an agency technical report on the classification and labelling of talc (not containing asbestos or asbestiform fibres). The report concludes talc meets STOT RE 1 (H372; lungs; inhalation) but states that available data are insufficient to support classification for carcinogenicity. This provides authoritative UK position and highlights potential EU/UK divergence for talc hazard classification and resulting labeling/SDS obligations for products placed on the GB market.
FDA published a Federal Register notice withdrawing its proposed rule that would have established standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products (a MoCRA-related proposal). For compliance teams, this means the previously proposed federal framework for standardized talc/asbestos testing methods is not proceeding as proposed, and companies should monitor for a replacement proposed rule to satisfy MoCRA section 3505. The withdrawal affects regulatory planning for cosmetics quality/testing programs, supplier specifications, and method validation strategies tied to FDA-standardized methods.
An official European Commission DG SANTE SCoPAFF summary report includes a dedicated section on talc, confirming the current regulatory pipeline under the EU CLP harmonised classification process: talc currently has no harmonised classification; the CLH process started in 2021; the ECHA RAC opinion was published in July 2025 proposing classification as Carcinogen Category 1B and STOT RE Category 1 (lungs, primarily inhalation); and the next step is adoption of the classification by the European Commission. For compliance teams, this is an official status update indicating continued progression toward an EU-wide harmonised hazard classification for talc (but not yet a legally binding Annex VI entry), supporting ongoing monitoring and impact assessment (e.g., downstream effects in sectoral rules that key off CMR status).